Adagio Medical COO Hakon Bergheim departs in corporate restructuring

Adagio Medical Holdings, Inc.

Hakon Bergheim, Chief Operating Officer, departed effective February 28, 2025.
Departure is part of a corporate restructuring announced on February 28, 2025.
No new compensatory arrangement entered into; severance package currently being negotiated.
Material terms of any severance agreement will be disclosed via future 8-K amendment if finalized.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Hakon Bergheim

Chief Operating Officer

ADGM · Adagio Medical Holdings, Inc.

Effective: 2025-02-28
Filed: March 4, 2025, 6:59 PM ET

As part of its corporate restructuring announced on February 28, 2025, Adagio Medical Holdings, Inc. (the “Company”), announced the departure of Hakon Bergheim, the Company’s Chief Operating Officer, effective February 28, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hakon Bergheim departed as Chief Operating Officer at Adagio Medical Holdings, Inc..

Action: departed
Role: Chief Operating Officer

Exact text from the filing

As part of its corporate restructuring announced on February 28, 2025, Adagio Medical Holdings, Inc. (the “Company”), announced the departure of Hakon Bergheim, the Company’s Chief Operating Officer, effective February 28, 2025.

View on SEC.gov

Adagio Medical Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-020319

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.